Natural Alternatives International (NASDAQ:NAII) Earns Buy Rating from Analysts at StockNews.com

Posted by Donna Armstrong on Nov 22nd, 2024

StockNews.com initiated coverage on shares of Natural Alternatives International (NASDAQ:NAII – Free Report) in a research report report published on Monday. The firm issued a buy rating on the stock.

Natural Alternatives International Stock Performance

Shares of Natural Alternatives International stock opened at $4.25 on Monday. The firm has a 50 day simple moving average of $5.04 and a 200 day simple moving average of $5.69. Natural Alternatives International has a fifty-two week low of $4.13 and a fifty-two week high of $7.37. The company has a debt-to-equity ratio of 0.11, a current ratio of 2.56 and a quick ratio of 1.50. The firm has a market cap of $26.35 million, a P/E ratio of -2.88 and a beta of 0.58.

Natural Alternatives International (NASDAQ:NAII – Get Free Report) last released its earnings results on Friday, September 27th. The company reported ($0.32) EPS for the quarter. Natural Alternatives International had a negative net margin of 7.53% and a negative return on equity of 10.23%. The firm had revenue of $29.49 million during the quarter.

Institutional Inflows and Outflows

An institutional investor recently raised its position in Natural Alternatives International stock. Geode Capital Management LLC increased its holdings in shares of Natural Alternatives International, Inc. (NASDAQ:NAII – Free Report) by 6.9% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 45,062 shares of the company’s stock after buying an additional 2,915 shares during the period. Geode Capital Management LLC owned 0.73% of Natural Alternatives International worth $258,000 at the end of the most recent quarter. 32.40% of the stock is owned by hedge funds and other institutional investors.

About Natural Alternatives International

(Get Free Report)

Natural Alternatives International, Inc engages in formulating, manufacturing, and marketing nutritional supplements in the United States, Europe, Australia, Asia, Mexico, and Canada. The company operates in two segments, Private-Label Contract Manufacturing, and Patent and Trademark Licensing. It offers private-label contract manufacturing services to companies that market and distribute vitamins, minerals, herbal, and other nutritional supplements, as well as other health care products.